Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
European Journal of Gynaecological Oncology
|
August 25, 2009
Patterns of surgical care for uterine cancers in Ontario
L Elit, S Schultz, R Prysbysz, et al.
European Journal of Gynaecological Oncology
|
November 11, 2009
Patterns of care in the initial management of women with vulvar cancers in Ontario
L Elit, S Schultz, R Prysbysz, et al.
Gynecologic Oncology
|
May 15, 2007
Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline
L Elit, L Zitzelsberger, M Fung-Kee-Fung, et al.
European Journal of Gynaecological Oncology
|
July 4, 2002
Familial and hormonal risk factors for papillary serous uterine cancer
L Elit, T Pal, R Goshen, et al.
Clinical Genetics
|
March 6, 2009
Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene
A Finch, K Metcalfe, J Lui, et al.
Gynecologic Oncology
|
April 16, 2003
Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)
A M Oza, L Elit, K Swenerton, et al.
Gynecologic Oncology
|
January 11, 2011
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation
A Finch, K A Metcalfe, J K Chiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 31, 2011
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)
C Kollmannsberger, H Hirte, L L Siu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2011
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
L Gladieff, A Ferrero, G De Rauglaudre, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 22, 2005
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies
L H Lê, K D Swenerton, L Elit, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
European Journal of Gynaecological Oncology
|
August 25, 2009
Patterns of surgical care for uterine cancers in Ontario
L Elit, S Schultz, R Prysbysz, et al.
European Journal of Gynaecological Oncology
|
November 11, 2009
Patterns of care in the initial management of women with vulvar cancers in Ontario
L Elit, S Schultz, R Prysbysz, et al.
Gynecologic Oncology
|
May 15, 2007
Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guideline
L Elit, L Zitzelsberger, M Fung-Kee-Fung, et al.
European Journal of Gynaecological Oncology
|
July 4, 2002
Familial and hormonal risk factors for papillary serous uterine cancer
L Elit, T Pal, R Goshen, et al.
Clinical Genetics
|
March 6, 2009
Breast and ovarian cancer risk perception after prophylactic salpingo-oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene
A Finch, K Metcalfe, J Lui, et al.
Gynecologic Oncology
|
April 16, 2003
Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)
A M Oza, L Elit, K Swenerton, et al.
Gynecologic Oncology
|
January 11, 2011
The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation
A Finch, K A Metcalfe, J K Chiang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 31, 2011
Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)
C Kollmannsberger, H Hirte, L L Siu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 7, 2011
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
L Gladieff, A Ferrero, G De Rauglaudre, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 22, 2005
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies
L H Lê, K D Swenerton, L Elit, et al.
Page
of 7